Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with nasopharyngeal carcinoma Post date 19 June 2024 ← David Oliver: Will the actions pledged in Labour’s election manifesto save health and social care? → Continuous observation for self-harm may be effective in psychiatric settings globally